Literature DB >> 22216992

A pilot training program for a motivational enhancement approach to hepatitis C virus treatment among individuals in Israeli methadone treatment centers.

Diane S Morse1, Miriam Schiff, Shabtay Levit, Rinat Cohen-Moreno, Geoffrey C Williams, Yehuda Neumark.   

Abstract

Although hepatitis C virus (HCV) can be cleared, very few infected persons complete the treatment, resulting in disease progression and transmission. Motivational interventions effectively address health and substance-use-related conditions in many cultures. The research team piloted an HCV treatment motivational enhancement training and supervision for four counselors treating four patients in one (of 11) large methadone programs in Israel between 2007 and 2008. The counselors received a 3-day training followed by seven supervision sessions. Training included cultural and language adaptation from the original United States version to practice in Israel. Feasibility was assessed and demonstrated through training field notes and questionnaire feedback, review of taped intervention sessions for counselor proficiency and patient engagement, and patient completion of intervention sessions and piloted measures. While positive feasibility outcomes were noted, future studies should employ larger numbers of counselors and patients to assess the effectiveness of motivational enhancement in promoting HCV treatment in methadone patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22216992      PMCID: PMC3305804          DOI: 10.3109/10826084.2011.628735

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  51 in total

1.  Improving take-up of hepatitis C services.

Authors:  Louise Tiffen; Susan Sheridan
Journal:  Nurs Times       Date:  2002 Oct 22-28

2.  Hepatitis C, illicit drug use and public health: does Canada really have a viable plan?

Authors:  Benedikt Fischer; Kate Kalousek; Jürgen Rehm; Jeff Powis; Mel Krajden; Jens Reimer
Journal:  Can J Public Health       Date:  2006 Nov-Dec

3.  Informed decision making in outpatient practice: time to get back to basics.

Authors:  C H Braddock; K A Edwards; N M Hasenberg; T L Laidley; W Levinson
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

4.  Referral for chronic hepatitis C treatment from a drug dependency treatment setting.

Authors:  Richard Hallinan; Andrew Byrne; Kingsley Agho; Gregory J Dore
Journal:  Drug Alcohol Depend       Date:  2006-10-25       Impact factor: 4.492

5.  Treatment rates in patients with chronic hepatitis C after liver biopsy.

Authors:  G Narasimhan; T N Sargios; R Kalakuntla; P Homel; D J Clain; N D Theise; H C Bodenheimer; A D Min
Journal:  J Viral Hepat       Date:  2006-11       Impact factor: 3.728

6.  Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

Authors:  Anna Doab; Carla Treloar; Gregory J Dore
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

7.  The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer.

Authors:  B L Fife; E R Wright
Journal:  J Health Soc Behav       Date:  2000-03

8.  Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients.

Authors:  Sarah L George; Bruce R Bacon; Elizabeth M Brunt; Kusal L Mihindukulasuriya; Joyce Hoffmann; Adrian M Di Bisceglie
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

9.  Majority of patients with hepatitis C express physical, mental, and social difficulties with antiviral treatment.

Authors:  Susan L Zickmund; Cindy L Bryce; Julie A Blasiole; Laura Shinkunas; Douglas R LaBrecque; Robert M Arnold
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-04       Impact factor: 2.566

10.  Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.

Authors:  Charlotte H S B van den Berg; Colette Smit; Margreet Bakker; Ronald B Geskus; Ben Berkhout; Suzanne Jurriaans; Roel A Coutinho; Katja C Wolthers; Maria Prins
Journal:  Eur J Epidemiol       Date:  2007-03-03       Impact factor: 8.082

View more
  4 in total

1.  Unmet core needs for self-determination in HIV-infected women of color in medical care.

Authors:  E B Quinlivan; L C Messer; K Roytburd; A Blickman
Journal:  AIDS Care       Date:  2016-10-13

2.  "They didn't give up on me": a women's transitions clinic from the perspective of re-entering women.

Authors:  Katherine Thomas; John L Wilson; Precious Bedell; Diane S Morse
Journal:  Addict Sci Clin Pract       Date:  2019-04-02

3.  Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model.

Authors:  Edward R Cachay; Lucas Hill; Craig Ballard; Bradford Colwell; Francesca Torriani; David Wyles; William C Mathews
Journal:  AIDS Res Ther       Date:  2013-03-28       Impact factor: 2.250

4.  Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care.

Authors:  Bernd Schulte; Christiane Sybille Schmidt; Olaf Kuhnigk; Ingo Schäfer; Benedikt Fischer; Heiner Wedemeyer; Jens Reimer
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.